Exelixis Inc
(NAS:EXEL)
$
36.115
0.265 (0.74%)
Market Cap: 10.31 Bil
Enterprise Value: 9.21 Bil
PE Ratio: 23.15
PB Ratio: 4.54
GF Score: 91/100 Exelixis Inc at Guggenheim Healthcare Talks Biotechnology Conference Transcript
Feb 08, 2024 / 02:00PM GMT
Release Date Price:
$20.17
(-0.05%)
Michael Werner Schmidt
Guggenheim Securities, LLC, Research Division - Senior Analyst & Senior MD
All right. Good morning, and welcome to the fireside chat with Exelixis. With us today, we have Mike Morrissey, CEO. Mike, welcome. Thanks for joining us.
Michael M. Morrissey
Exelixis, Inc. - CEO, President & Director
Michael, good to see you. Great glasses.
Michael Werner Schmidt
Guggenheim Securities, LLC, Research Division - Senior Analyst & Senior MD
Thank you. Appreciate it.
Questions & Answers
Michael Werner Schmidt
Guggenheim Securities, LLC, Research Division - Senior Analyst & Senior MD
So yes, for those who don't know, I'm Michael Schmidt, biotech analysts with Guggenheim and we'll just jump right into Q&A, Mike. Perhaps starting just with a quick commercial question. You recently guided to 2024 revenue, [$1.65 billion to 1.75 billion] cabo sales for this year, which implies a slowdown from the prior year. Just remind folks again,
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot